Nausea as a mediator of olanzapine's effect on quality-of-life improvement: Insights from a phase III NCORP RCT

Authors

Kevin Spath
Chunkit Fung
Joseph John Guido
Gary R. Morrow
Michelle Christine Janelsins
Charles Stewart Kamen
Jeremy McGuire
Lindsey Jean Mattick
Chin-Shang Li
Thomas James Saphner, Advocate Health - MidwestFollow
Samer Kasbari
Priya Kumar
Luke Joseph Peppone

Recommended Citation

Spath K, Fung C, Guido JJ, et al. Nausea as a mediator of olanzapine’s effect on quality-of-life improvement: Insights from a phase III NCORP RCT. JCO Oncology Practice. 2025;21(10_suppl):352-352. doi:10.1200/OP.2025.21.10_suppl.352

Affiliations

Aurora Health, Two Rivers, WI

Document Type

Abstract